Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Curr Opin Neurobiol. 2012 May 4;22(5):895–901. doi: 10.1016/j.conb.2012.04.008

Figure 1.

Figure 1

Some milestones in defining the pathophysiology of tuberous sclerosis complex (TSC). The current therapeutic efforts in the neurocognitive phenotype of TSC patients stem from the contributions from two independent lines of research: clinical advances in genetics and phenotyping of TSC (left timeline) and basic research on the TSC-mTOR pathway and mouse models (right timeline). See text for details.